昭衍新药(06127.HK)就参投北脑一期(北京)股权投资中心(有限合伙)签署合伙协议

智通财经
Aug 27
【昭衍新药(06127.HK)就参投北脑一期(北京)股权投资中心(有限合伙)签署合伙协议】智通财经APP讯,昭衍新药(06127.HK)公布,公司于 2024 年 12 月 20 日召开第四届董事会第十一次会议,审议通过了《关于公司与专业投资机构合作参与投资基金的议案》,同意公司或其指定子公司以不超过 800 万元人民币投资参与投资北脑一期(北京)股权投资中心(有限合伙)。近日,公司全资子公司北京昭衍管理科技有限公司与北京崇德英盛投资管理有限公司及参与本基金的其他合伙人共同签署了合伙协议。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10